{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"69.7","upperLimit":"96.7","value":"88.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"The percentage of patients with complete response (CR) at the end of therapy (\\~273 days) was reported and presented with the associated exact 95% confidence interval.","dispersionType":"95% Confidence Interval","groups":[{"description":"All eligible patients enrolled on the study","id":"OG000","title":"All Eligible Patients (Combination Chemotherapy)"}],"paramType":"NUMBER","populationDescription":"26 patients were enrolled on the protocol, but 1 was deemed ineligible. The ineligible patient is excluded from all analyses.","reportingStatus":"POSTED","timeFrame":"273 days from start of treatment","title":"Percentage of Patients With Responses at 273 Days","type":"PRIMARY","unitOfMeasure":"Percentage of patients"}